@article{3165558,
    title = "PREDICTORS OF CLINICAL RESPONSE: RESULTS FROM A LARGE, RANDOMIZED
CONTROLLED STUDY WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) PLUS
PEGINTERFERON ALFA-2A (PEG) COMBINATION FOR CHRONIC HEPATITIS B (CHB)",
    author = "Chan, H. L. and Ahn, S. H. and Chuang, W. L. and Hui, A. J. and Tabak, and F. and Mehta, R. and Petersen, J. and Lee, C. -M. and Ma, X. and and Caruntu, F. A. and Tak, W. Y. and Elkhashab, M. and Lin, L. and Dinh, P. and and Martins, E. B. and Charuworn, P. and McHutchinson, J. G. and and Subramanian, G. M. and Lim, S. G. and Foster, G. R. and Fung, S. and and Morano, L. and Samuel, D. and Agarwal, K. and Idilman, R. and Strasser, and S. and Buti, M. and Gaeta, G. B. and Papatheodoridis, G. and Flisiak, R. and and Marcellin, P.",
    journal = "WORLD JOURNAL OF HEPATOLOGY",
    year = "2015",
    volume = "62",
    number = "2",
    pages = "S251-S252",
    publisher = "ELSEVIER SCIENCE BV",
    doi = "10.1016/S0168-8278(15)30136-7"
}